Home LiteratureArticle Details
PMID: 4363786 Published · ppublish English Journal Article

Effect of polymyxin B on antibiotic-resistant Proteus mirabilis.

Antimicrobial agents and chemotherapy ·Vol. 1 ·No. 5 ·1972-05-00 ·Pages 417-21

Sud IJ, Feingold DS

Abstract

The surface properties of polymyxin B-resistant Proteus mirabilis are markedly altered by the antibiotic. The effects include the development of susceptibility to surface-active agents such as deoxycholate or tris(hydroxymethyl)aminomethane and a marked increased osmotic fragility. However, cell wall impermeability to various agents such as erythromycin, actinomycin D, bacitracin, lysozyme, and triphenyltetrazolium chloride apparently remains intact. These results support the concept that the actions of the polymyxins on gram-negative bacteria are multiple; the action(s) of the antibiotic responsible for lethality in vitro, presumably at the level of the cytoplasmic membrane, may represent only a portion of the potential therapeutic effects of the antibiotic in vivo.

MeSH Terms
Deoxycholic Acid/pharmacology Drug Resistance, Microbial Osmotic Fragility Polymyxins/pharmacology Proteus mirabilis/drug effects
Chemicals
Polymyxins Deoxycholic Acid
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Sud I J
Feingold D S
References (15)
15 references, click to expand
  1. Mechanism of polymyxin B resistance in Proteus mirabilis.
    J Bacteriol. 1970 Oct;104(1):289-94 PMID: 4319722
  2. Resistance of Escherichia coli to penicillins. 8. Physiology of a class II ampicillin-resistant mutant.
    J Bacteriol. 1970 Mar;101(3):659-68 PMID: 4985589
  3. Comparison between the polymyxins and gentamicin in preventing endotoxin-induced intravascular coagulation and leukopenia.
    Infect Immun. 1971 Nov;4(5):563-6 PMID: 4343409
  4. The absorption of polymyxin E by bacteria and bacterial cell walls and its bactericidal action.
    J Gen Microbiol. 1953 Dec;9(3):454-66 PMID: 13118093
  5. Susceptibility of Proteus mirabilis and its stable L-forms to erythromycin and other macrolides.
    Nature. 1962 Oct 13;196:195-6 PMID: 13993473
  6. A NONSPECIFIC INCREASE IN PERMEABILITY IN ESCHERICHIA COLI PRODUCED BY EDTA.
    Proc Natl Acad Sci U S A. 1965 Apr;53:745-50 PMID: 14324530
  7. The properties and mode of action of the polymyxins.
    Bacteriol Rev. 1956 Mar;20(1):14-27 PMID: 13303920
  8. Neutralization of endotoxin toxicity in chick embryos by antibiotics.
    J Bacteriol. 1966 Oct;92(4):815-9 PMID: 4288800
  9. Controlling EDTA treatment to produce permeable Escherichia coli with normal metabolic processes.
    Biochem Biophys Res Commun. 1967 Jul 21;28(2):229-36 PMID: 4166571
  10. Studies on the interaction between endotoxin and polymyxin B.
    J Infect Dis. 1967 Dec;117(5):433-8 PMID: 4294922
  11. Electron microscopic studies on mode of action of polymyxin.
    J Bacteriol. 1969 Jan;97(1):448-52 PMID: 4303542
  12. Susceptibility to polymyxin B in penicillin G-induced Proteus mirabilis L forms and spheroplasts.
    J Bacteriol. 1969 May;98(2):347-50 PMID: 4306537
  13. The serum bactericidal reaction. IV. Phenotypic conversion of Escherichia coli from serum-resistance to serum-sensitivity by diphenylamine.
    J Infect Dis. 1969 Oct;120(4):437-44 PMID: 4898784
  14. Electron microscopy of effect of polymyxin on Escherichia coli lipopolysaccharide.
    J Bacteriol. 1969 Nov;100(2):1128-9 PMID: 4311679
  15. The cell envelope in Proteus vulgaris P 18. Isolation and characterization of the peptidoglycan component.
    Biochim Biophys Acta. 1971 Jun 1;233(3):489-503 PMID: 4255900
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1972-05-00
Pages
417-21
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC444235
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com